Table 3.

Association between Psf3 expression and clinicopathological characteristics in 109 patients with adenocarcinoma

Factor	Total	Psf3		P‐value
		Positive	Negative
No. of patients (%)	109	59 (53.2)	50 (46.8)
Age, years (mean ± SD)	64.5 ± 10.8	63.5 ± 11.8	65.7 ± 9.7	0.283
Gender (male/female)	62/47	41/18	21/29	0.004a
Brinkman index (≥400/<400)	46/63	32/27	14/36	0.005a
Pathologic stage (I/II/III/IV)	62/24/19/4	28/17/12/2	34/7/7/2	0.141
T factor (T1/T2/T3/T4)	51/42/11/5	21/27/8/3	30/15/3/2	0.075
N factor (N0/N1/N2)	74/21/14	37/13/9	37/8/5	0.445
M factor (M0/M1)	105/4	57/2	48/2	0.866
Vessel invasion (negative/positive)	66/43	27/32	39/11	<0.001a
Lymphatic invasion (negative/positive)	53/56	19/40	34/16	<0.001a
Pleural invasion (negative/positive)	73/36	33/26	40/10	0.007a
Surgery				0.019a
Lobectomy	83	51	32
Segmentectomy/wedge	24	7	17
Pneumonectomy	2	1	1

^aStatistically significant.